Home » QRxPharma, FDA Establish Path Forward for Resubmission of Moxduo NDA
QRxPharma, FDA Establish Path Forward for Resubmission of Moxduo NDA
QRxPharma Limited announced the steps necessary for approval of immediate release Moxduo (morphine and oxycodone) have been clarified with the FDA.
Daily Markets
Daily Markets
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May